← Ryan Specialty overview

Ryan Specialty vs Marsh & McLennan Companies: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Ryan Specialty Group Holdings Inc (RYAN)

Marsh & McLennan Companies, Inc. (MRSH)

Q3 2026
▲3

Marsh grows on health-cost demand, buybacks, AI push despite falling insurance rates

  • Q2 beat, buybacks and 10% dividend hike Marsh reported 6% revenue growth and 9% higher adjusted EPS, bought back $750 million of stock and raised its dividend 10% for a 17th straight year. Steady profit and cash returned to shareholders support the share price.

    The quarter's results and capital returns are the core new financial facts driving the stock.

  • Health-cost surge lifts benefits consulting demand Marsh's survey projects US employer health costs will jump 8.2% in 2027, the steepest since 2003. Rising costs push employers to seek Marsh's benefits advice, supporting demand for its consulting business and its revenue outlook.

    This is the period's biggest demand driver for Marsh's consulting arm.

  • Falling insurance rates offset by AI and new services Commercial insurance rates fell 6% and property rates 12%, a headwind to brokerage commissions. Marsh is countering with AI tools like Risk Companion and new offerings such as Archer, which add recurring service revenue and broaden its mix.

    It captures the main negative force on pricing and the company's response.

  • Analysts see 2026 earnings up 7.1% Zacks notes rising 2026 earnings estimates, a $5.5 billion capital deployment plan and management consulting growing 13.4% organically, its fastest in over two years. Upward revisions and expected Q3 beat support the stock.

    Analyst estimate momentum and capital plans are a key forward-looking driver.

August 2026
▲3

Marsh grows on health-cost demand, buybacks, AI push despite falling insurance rates

  • Q2 beat, buybacks and 10% dividend hike Marsh reported 6% revenue growth and 9% higher adjusted EPS, bought back $750 million of stock and raised its dividend 10% for a 17th straight year. Steady profit and cash returned to shareholders support the share price.

    The quarter's results and capital returns are the core new financial facts driving the stock.

  • Health-cost surge lifts benefits consulting demand Marsh's survey projects US employer health costs will jump 8.2% in 2027, the steepest since 2003. Rising costs push employers to seek Marsh's benefits advice, supporting demand for its consulting business and its revenue outlook.

    This is the period's biggest demand driver for Marsh's consulting arm.

  • Falling insurance rates offset by AI and new services Commercial insurance rates fell 6% and property rates 12%, a headwind to brokerage commissions. Marsh is countering with AI tools like Risk Companion and new offerings such as Archer, which add recurring service revenue and broaden its mix.

    It captures the main negative force on pricing and the company's response.

  • Analysts see 2026 earnings up 7.1% Zacks notes rising 2026 earnings estimates, a $5.5 billion capital deployment plan and management consulting growing 13.4% organically, its fastest in over two years. Upward revisions and expected Q3 beat support the stock.

    Analyst estimate momentum and capital plans are a key forward-looking driver.

Latest
▲3

Marsh grows on health-cost demand, buybacks, AI push despite falling insurance rates

  • Q2 beat, buybacks and 10% dividend hike Marsh reported 6% revenue growth and 9% higher adjusted EPS, bought back $750 million of stock and raised its dividend 10% for a 17th straight year. Steady profit and cash returned to shareholders support the share price.

    The quarter's results and capital returns are the core new financial facts driving the stock.

  • Health-cost surge lifts benefits consulting demand Marsh's survey projects US employer health costs will jump 8.2% in 2027, the steepest since 2003. Rising costs push employers to seek Marsh's benefits advice, supporting demand for its consulting business and its revenue outlook.

    This is the period's biggest demand driver for Marsh's consulting arm.

  • Falling insurance rates offset by AI and new services Commercial insurance rates fell 6% and property rates 12%, a headwind to brokerage commissions. Marsh is countering with AI tools like Risk Companion and new offerings such as Archer, which add recurring service revenue and broaden its mix.

    It captures the main negative force on pricing and the company's response.

  • Analysts see 2026 earnings up 7.1% Zacks notes rising 2026 earnings estimates, a $5.5 billion capital deployment plan and management consulting growing 13.4% organically, its fastest in over two years. Upward revisions and expected Q3 beat support the stock.

    Analyst estimate momentum and capital plans are a key forward-looking driver.